Real-World Data on Access to Standards of Care for People With Spinal Muscular Atrophy in the UK

Robert Muni-Lofra, Lindsay B Murphy, Kate Adcock, Maria E Farrugia, Joseph Irwin, James B Lilleker, John McConville, Andria Merrison, Matt Parton, Liz Ryburn, Mariacristina Scoto, Chiara Marini-Bettolo, Anna Mayhew, Robert Muni-Lofra, Lindsay B Murphy, Kate Adcock, Maria E Farrugia, Joseph Irwin, James B Lilleker, John McConville, Andria Merrison, Matt Parton, Liz Ryburn, Mariacristina Scoto, Chiara Marini-Bettolo, Anna Mayhew

Abstract

Spinal Muscular Atrophy (SMA) is characterized by muscle atrophy and weakness and has an incidence of 1:11. 000 live births which projects an estimated population in the UK of 650-1,300 affected patients. Standards of Care (SoC) were updated in 2017 and they have been widely adopted as a reference for implementation of care in SMA across the globe. The effectiveness of implementation and adherence to these standards across different countries is unclear. The aim of this study is to describe the experience of individuals with SMA regarding their care in the UK. An online anonymised survey was sent out via patient organizations, the UK SMA Patient Registry, professional networks, and social media to reach across the UK. The survey captured demographic profile, professionals involved in a patient's care, Interventions and access to mobility aids and home adaptations. Participants responded about their access to services and to rate how important each professional and intervention was for their health and wellbeing. One hundred and twenty-eight responses were collected with a median age of 34 years (1-81). Seventy-three percent of participants were adults and 60% men. Overall good access to neurologist (>90%) but limited to nurse specialist (48%) and physiotherapist (57%). Good access to respiratory support was reported but limited for interventions for positioning and bracing and exercise. This survey highlights that access to certain professionals for people with SMA is limited in the UK. Striking differences were noted between pediatric and adult populations. Limited access to care were regularly reported, with half of the study population consistently not accessing full multidisciplinary care. Access to interventions for contracture management were recorded to have significant limitations. Mobility aids and home adaptations are widely available and were also reported as the most valued interventions. Access to nutritional support or speech and language therapy appears only to be available for a small proportion of the participants. Access to respiratory care was good especially in severe forms of SMA. We found pockets of good practice in the UK that align with the SoC. However, access is not equal for adults and children and access to certain professionals is significantly limited.

Keywords: United Kingdom; neuromuscular diseases; real-world data; spinal muscular atrophy; standards of care.

Conflict of interest statement

LR was employed by SMAUK. JI was employed by Treat SMA and KA was employed by MDUK. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2022 Muni-Lofra, Murphy, Adcock, Farrugia, Irwin, Lilleker, McConville, Merrison, Parton, Ryburn, Scoto, Marini-Bettolo and Mayhew.

Figures

Figure 1
Figure 1
SMA type and current functional status distribution.

References

    1. Kolb SJ, Kissel JT. Spinal muscular atrophy. Neurol Clin. (2015) 33:831–46. 10.1016/j.ncl.2015.07.004
    1. Sugarman EA, Nagan N, Zhu H, Akmaev VR, Zhou Z, Rohlfs EM, et al. . Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens. Eur J Hum Genet. (2012) 20:27–32. 10.1038/ejhg.2011.134
    1. Verhaart IEC, Robertson A, Wilson IJ, Aartsma-Rus A, Cameron S, Jones CC, et al. . Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review. Orphanet J Rare Dis. (2017) 12:124. 10.1186/s13023-017-0671-8
    1. Wang CH, Finkel RS, Bertini ES, Schroth M, Simonds A, Wong B, et al. . Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol. (2007) 22:1027–49. 10.1177/0883073807305788
    1. Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, et al. . Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord. (2018) 28:103–15. 10.1016/j.nmd.2017.11.005
    1. Finkel RS, Mercuri E, Meyer OH, Simonds AK, Schroth MK, Graham RJ, et al. . Diagnosis and management of Spinal Muscular Atrophy: Part 2: pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscul Disord. (2018) 28:197–207. 10.1016/j.nmd.2017.11.004
    1. Montes J, Garber CE, Kramer SS, Montgomery MJ, Dunaway S, Kamil-Rosenberg S, et al. . Single-blind, randomized, controlled clinical trial of exercise in ambulatory spinal muscular atrophy: why are the results negative? J Neuromuscul Dis. (2015) 2:463–70. 10.3233/JND-150101
    1. Madsen KL, Hansen RS, Preisler N, Thøgersen F, Berthelsen MP, Vissing J. Training improves oxidative capacity, but not function, in spinal muscular atrophy type III. Muscle Nerve. (2015) 52:240–4. 10.1002/mus.24527
    1. Lewelt A, Krosschell KJ, Stoddard GJ, Weng C, Xue M, Marcus RL, et al. . Resistance strength training exercise in children with spinal muscular atrophy. Muscle Nerve. (2015) 52:559–67. 10.1002/mus.24568
    1. Cunha MC, Oliveira AS, Labronici RH, Gabbai AA. Spinal muscular atrophy type II (intermediary) and III (Kugelberg-Welander). Evolution of 50 patients with physiotherapy and hydrotherapy in a swimming pool. Arq Neuropsiquiatr. (1996) 54:402–6. 10.1590/S0004-282X1996000300007
    1. Salem Y, Gropack SJ. Aquatic therapy for a child with type III spinal muscular atrophy: a case report. Phys Occup Ther Pediatr. (2010) 30:313–24. 10.3109/01942638.2010.493097
    1. Fujak A, Kopschina C, Forst R, Mueller LA, Forst J. Use of orthoses and orthopaedic technical devices in proximal spinal muscular atrophy. Results of survey in 194 SMA patients. Disabil Rehabil Technol. (2011) 6:305–11. 10.3109/17483107.2010.525292
    1. Hartley S, Stockley R. It's more than just physical therapy: reported utilization of physiotherapy services for adults with neuromuscular disorders attending a specialist centre. Disabil Rehabil. (2013) 35:282–90. 10.3109/09638288.2012.691940
    1. Finkel RS, Bishop KM, Nelson RM. Spinal muscular atrophy type I: is it ethical to standardize supportive care intervention in clinical trials? J Child Neurol. (2017) 32:155–60. 10.1177/0883073816671236
    1. Bladen CL, Thompson R, Jackson JM, Garland C, Wegel C, Ambrosini A, et al. . Mapping the differences in care for 5,000 spinal muscular atrophy patients, a survey of 24 national registries in North America, Australasia and Europe. J Neurol. (2014) 261:152–63. 10.1007/s00415-013-7154-1
    1. Qian Y, McGraw S, Henne J, Jarecki J, Hobby K, Yeh W-SS. Understanding the experiences and needs of individuals with Spinal Muscular Atrophy and their parents: a qualitative study. BMC Neurol. (2012) 15:217. 10.1186/s12883-015-0473-3
    1. Cook C, Heath F, Thompson RL. A meta-analysis of response rates in Web- or internet-based surveys. Educ Psychol Meas. (2000) 60:821–36. 10.1177/00131640021970934
    1. Wijngaarde CA, Stam M, Otto LAM, Bartels B, Asselman F-L, van Eijk RPA, et al. . Muscle strength and motor function in adolescents and adults with spinal muscular atrophy. Neurology. (2020) 95:e1988–e98. 10.1212/WNL.0000000000010540
    1. Samaha FJ, Buncher CR, Russman BS, White ML, Iannaccone ST, Barker L, et al. . Pulmonary function in spinal muscular atrophy. J Child Neurol. (1994) 9:326–9. 10.1177/088307389400900321

Source: PubMed

3
订阅